Cargando…

Health Care Transition From Pediatric- to Adult-Focused Care in X-linked Hypophosphatemia: Expert Consensus

CONTEXT: X-linked hypophosphatemia (XLH) is an inherited skeletal disorder that can lead to lifelong deleterious musculoskeletal and functional consequences. Although often perceived as a childhood condition, children and adults both experience the negative effects of XLH. Adolescents and young adul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dahir, Kathryn, Dhaliwal, Ruban, Simmons, Jill, Imel, Erik A, Gottesman, Gary S, Mahan, John D, Prakasam, Gnanagurudasan, Hoch, Allison I, Ramesan, Prameela, Díaz-González de Ferris, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Mini-Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8852209/ https://www.ncbi.nlm.nih.gov/pubmed/34741521 http://dx.doi.org/10.1210/clinem/dgab796

Ejemplares similares

X-Linked Hypophosphatemia: A New Era in Management
por: Dahir, Kathryn, et al.
Publicado: (2020)

OR13-3 Hypophosphatemia Gene Panel Sponsored Program: A High Yield of Molecular Diagnoses from Clinically Confirmed XLH and Suspected Genetic Hypophosphatemia
por: Japalaghi, Omid K, et al.
Publicado: (2022)

Hypophosphatemia Gene Panel Sponsored Program: A High Yield of Molecular Diagnoses from Clinically Confirmed XLH and Suspected Genetic Hypophosphatemia
por: Dahir, Kathryn, et al.
Publicado: (2021)

SUN-363 Hypophosphatemia Gene Panel Sponsored Program: A High Yield Of Molecular Diagnoses from Clinically Confirmed XLH and Suspected XLH/ Genetic Hypophosphatemia
por: Miller, Nicole, et al.
Publicado: (2020)

Molecular Diagnoses of X‐Linked and Other Genetic Hypophosphatemias: Results From a Sponsored Genetic Testing Program
por: Rush, Eric T., et al.
Publicado: (2021)

X‐Linked Hypophosphatemia Caused by the Prevailing North American PHEX Variant c.*231A>G; Exon 13–15 Duplication Is Often Misdiagnosed as Ankylosing Spondylitis and Manifests in Both Men and Women
por: Dahir, Kathryn McCrystal, et al.
Publicado: (2022)

Novel PHEX gene locus‐specific database: Comprehensive characterization of vast number of variants associated with X‐linked hypophosphatemia (XLH)
por: Sarafrazi, Soodabeh, et al.
Publicado: (2021)

Enthesopathy, Osteoarthritis, and Mobility in X-linked Hypophosphatemia
por: Imel, Erik A
Publicado: (2020)

FGF23, Hypophosphatemia, and Emerging Treatments
por: Imel, Erik A, et al.
Publicado: (2019)

An Expert Perspective on Phosphate Dysregulation With a Focus on Chronic Hypophosphatemia
por: Aljuraibah, Fahad, et al.
Publicado: (2021)

Effect of Burosumab Compared With Conventional Therapy on Younger vs Older Children With X-linked Hypophosphatemia
por: Ward, Leanne M, et al.
Publicado: (2022)

SUN-526 Prevalence of Hyperparathyroidism in X-Linked Hypophosphatemia
por: DeLacey, Sean, et al.
Publicado: (2019)

Consensus Recommendations for the Diagnosis and Management of X-Linked Hypophosphatemia in Belgium
por: Laurent, Michaël R., et al.
Publicado: (2021)

Burosumab vs Phosphate/Active Vitamin D in Pediatric X-Linked Hypophosphatemia: A Subgroup Analysis by Dose Level
por: Imel, Erik A, et al.
Publicado: (2023)

Sustained Efficacy and Safety of Burosumab, a Monoclonal Antibody to FGF23, in Children With X-Linked Hypophosphatemia
por: Linglart, Agnès, et al.
Publicado: (2021)

Asia‐Pacific Consensus Recommendations on X‐Linked Hypophosphatemia: Diagnosis, Multidisciplinary Management, and Transition From Pediatric to Adult Care
por: Munns, Craig F, et al.
Publicado: (2023)

Corrigendum: Consensus Recommendations for the Diagnosis and Management of X-Linked Hypophosphatemia in Belgium
por: Laurent, Michaël R., et al.
Publicado: (2021)

OR13-2 Burosumab Resulted in Greater Improvement in Rickets Than Conventional Therapy in Children with X-Linked Hypophosphatemia (XLH)
por: Imel, Erik, et al.
Publicado: (2019)

Treatment of hypophosphatemia in the intensive care unit: a review
por: Geerse, Daniël A, et al.
Publicado: (2010)

Long-term Burosumab Administration Is Safe and Effective in Adults With X-linked Hypophosphatemia
por: Weber, Thomas J, et al.
Publicado: (2022)

Musculoskeletal Features in Adults With X-linked Hypophosphatemia: An Analysis of Clinical Trial and Survey Data
por: Javaid, Muhammad Kassim, et al.
Publicado: (2021)

Placebo effects in allergen immunotherapy: an experts’ opinion
por: Frew, Anthony J., et al.
Publicado: (2018)

Growth charts from controversy to consensus
por: Khadilkar, Vaman, et al.
Publicado: (2012)

The Lifelong Impact of X-Linked Hypophosphatemia: Results From a Burden of Disease Survey
por: Skrinar, Alison, et al.
Publicado: (2019)

The Association of Hypophosphatemia With Resistant Lactic Acidosis in Critical Care Illness
por: Essa, Amr, et al.
Publicado: (2020)

Nirogacestat and Hypophosphatemia
por: Gudsoorkar, Prakash, et al.
Publicado: (2023)

Holistic care for patients with severe coronavirus disease 2019: An expert consensus()
por: Wang, Hui, et al.
Publicado: (2020)

Patient-Reported Outcomes from a Randomized, Active-Controlled, Open-Label, Phase 3 Trial of Burosumab Versus Conventional Therapy in Children with X-Linked Hypophosphatemia
por: Padidela, Raja, et al.
Publicado: (2021)

Rare Diseases That Impersonate One Another: X‐Linked Hypophosphatemia and Tumor‐Induced Osteomalacia, a Retrospective Analysis of Discriminating Features
por: DeCorte, Joseph, et al.
Publicado: (2022)

SUN-356 Burosumab Resulted in Greater Clinical Improvements Compared with Higher-dose Conventional Therapy in Children with X-linked Hypophosphatemia (XLH)
por: Imel, Erik A, et al.
Publicado: (2020)

The Experts Consensus for Patient Management of Neurosurgical Critical Care Unit in China (2015)
Publicado: (2015)

Expert Consensus on Nurses’ Human Caring for COVID-19 Patients in Different Sites
por: Zhang, Feng-jian, et al.
Publicado: (2020)

Expert consensus on the diagnosis and treatment of thrombocytopenia in adult critical care patients in China
por: Song, Jing-Chun, et al.
Publicado: (2020)

Essential Emergency and Critical Care: a consensus among global clinical experts
por: Schell, Carl Otto, et al.
Publicado: (2021)

EXPERT CONSENSUS PANEL RECOMMENDATIONS FOR MEDICAL AND MENTAL HEALTH CARE IN ASSISTED LIVING
por: Zimmerman, Sheryl, et al.
Publicado: (2022)

Tumor-induced hypophosphatemia
por: Mulani, M., et al.
Publicado: (2017)

Hypophosphatemia in cancer patients
por: Adhikari, Shreedhar, et al.
Publicado: (2021)

Cardiovascular Manifestations From Therapeutic Radiation: A Multidisciplinary Expert Consensus Statement From the International Cardio-Oncology Society
por: Mitchell, Joshua D., et al.
Publicado: (2021)

Recommendations for Medical and Mental Health Care in Assisted Living Based on an Expert Delphi Consensus Panel: A Consensus Statement
por: Zimmerman, Sheryl, et al.
Publicado: (2022)

Toward a refined genotype–phenotype classification scheme for the international consensus classification of Focal Cortical Dysplasia
por: Blumcke, Ingmar, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6cvd72djakbai1uuto8550vauf